APT Neuroscience, Inc. (KOSDAQ:270520)
South Korea
· Delayed Price · Currency is KRW
1,220.00
+3.00 (0.25%)
Jun 16, 2025, 3:30 PM KST
APT Neuroscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 20,076 | 18,378 | 20,415 | 17,563 |
| Revenue Growth (YoY) | 16.74% | -9.98% | 16.24% | - |
| Cost of Revenue | 19,416 | 17,779 | 19,930 | 19,066 |
| Gross Profit | 659.62 | 599.04 | 485.67 | -1,503 |
| Selling, General & Admin | 7,212 | 7,344 | 6,330 | 2,744 |
| Research & Development | 6,002 | 5,063 | 93.8 | - |
| Other Operating Expenses | 232.19 | 221.16 | 149.57 | 66.97 |
| Operating Expenses | 14,123 | 13,351 | 7,232 | 1,629 |
| Operating Income | -13,464 | -12,752 | -6,746 | -3,133 |
| Interest Expense | -4,885 | -2,778 | -3,405 | -53.71 |
| Interest & Investment Income | 3,354 | 2,763 | 2,172 | 327.51 |
| Earnings From Equity Investments | -8,470 | -7,728 | -4,736 | - |
| Currency Exchange Gain (Loss) | -1.9 | 1.3 | 251.74 | 3.62 |
| Other Non Operating Income (Expenses) | 2,458 | 1,425 | 7,955 | -1,091 |
| EBT Excluding Unusual Items | -21,009 | -19,070 | -4,509 | -3,946 |
| Gain (Loss) on Sale of Investments | 12,726 | 69.75 | 87.36 | -38.71 |
| Gain (Loss) on Sale of Assets | -18.59 | -18.6 | -2.67 | -0.04 |
| Other Unusual Items | - | - | -32.72 | - |
| Pretax Income | -8,302 | -19,018 | -4,457 | -3,985 |
| Income Tax Expense | 148.44 | 148.44 | 546.14 | -737.05 |
| Net Income | -8,450 | -19,167 | -5,003 | -3,248 |
| Net Income to Common | -8,450 | -19,167 | -5,003 | -3,248 |
| Shares Outstanding (Basic) | 154 | 147 | 122 | 94 |
| Shares Outstanding (Diluted) | 154 | 147 | 156 | 94 |
| Shares Change (YoY) | 23.72% | -5.59% | 65.51% | - |
| EPS (Basic) | -54.83 | -130.31 | -40.99 | -34.50 |
| EPS (Diluted) | -54.83 | -130.31 | -59.47 | -35.00 |
| Free Cash Flow | -45,248 | -10,744 | -8,708 | 840.09 |
| Free Cash Flow Per Share | -293.57 | -73.05 | -55.89 | 8.93 |
| Gross Margin | 3.29% | 3.26% | 2.38% | -8.56% |
| Operating Margin | -67.06% | -69.39% | -33.05% | -17.84% |
| Profit Margin | -42.09% | -104.29% | -24.51% | -18.49% |
| Free Cash Flow Margin | -225.39% | -58.47% | -42.65% | 4.78% |
| EBITDA | -12,450 | -11,588 | -6,237 | -3,017 |
| EBITDA Margin | -62.01% | -63.06% | -30.55% | -17.18% |
| D&A For EBITDA | 1,014 | 1,164 | 509.66 | 115.59 |
| EBIT | -13,464 | -12,752 | -6,746 | -3,133 |
| EBIT Margin | -67.06% | -69.39% | -33.05% | -17.84% |
| Advertising Expenses | - | 24.1 | 60.68 | 8.6 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.